These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

34 related articles for article (PubMed ID: 8571995)

  • 1. Quantitative analysis of superb microvascular imaging for monitoring tumor response to chemoradiotherapy in locally advanced cervical cancer.
    Zhu Y; Tang Y; Zhang G; Zhang J; Li Y; Jiang Z
    Front Oncol; 2022; 12():1074173. PubMed ID: 36686825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histone Methyltransferase KMT2B Promotes Metastasis and Angiogenesis of Cervical Cancer by Upregulating EGF Expression.
    Zhao D; Yuan H; Fang Y; Gao J; Li H; Li M; Cong H; Zhang C; Liang Y; Li J; Yang H; Yao M; Du M; Tu H; Gan Y
    Int J Biol Sci; 2023; 19(1):34-49. PubMed ID: 36594087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive value of microvessel features for the clinical response to neoadjuvant chemotherapy in cervical squamous carcinoma and the associations with prognosis.
    Li W; Liang C; Liu P; Qi Y; Shen H; Li M; Chen C
    Transl Cancer Res; 2021 Jan; 10(1):162-173. PubMed ID: 35116248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of cervical vascularization density in patients with locally advanced squamous cell cervical carcinoma evaluated in colour Doppler and power Doppler functions.
    Tomalczyk A; Tomasik B; Fijuth J; Moszynska-Zielinska M; Gottwald L
    Arch Gynecol Obstet; 2022 Apr; 305(4):955-961. PubMed ID: 34586470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Comprehensive RNA Expression Signature for Cervical Squamous Cell Carcinoma Prognosis.
    Xiong J; Guo S; Bing Z; Su Y; Guo L
    Front Genet; 2018; 9():696. PubMed ID: 30662454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High Expression of CCDC34 Is Associated with Poor Survival in Cervical Cancer Patients.
    Liu LB; Huang J; Zhong JP; Ye GL; Xue L; Zhou MH; Huang G; Li SJ
    Med Sci Monit; 2018 Nov; 24():8383-8390. PubMed ID: 30458457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating soluble neuropilin-1 in patients with early cervical cancer and cervical intraepithelial neoplasia can be used as a valuable diagnostic biomarker.
    Yang S; Cheng H; Huang Z; Wang X; Wan Y; Cai J; Wang Z
    Dis Markers; 2015; 2015():506428. PubMed ID: 25873749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting angiogenesis in gynecologic cancers.
    Zand B; Coleman RL; Sood AK
    Hematol Oncol Clin North Am; 2012 Jun; 26(3):543-63, viii. PubMed ID: 22520979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of correlation between microvascular density and pathological features and outcomes in sinonasal and oral mucosal melanomas.
    Kerr EH; Wang D; Lewis JS; Said-Al-Naief N; Hameed O
    Head Neck Pathol; 2011 Sep; 5(3):199-204. PubMed ID: 21424261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic advances in women's cancers.
    Carroll AR; Coleman RL; Sood AK
    Front Biosci (Schol Ed); 2011 Jan; 3(1):82-97. PubMed ID: 21196359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of vascular endothelial growth factor inhibitors in the treatment of gynecologic malignancies.
    Burger RA
    J Gynecol Oncol; 2010 Mar; 21(1):3-11. PubMed ID: 20379441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Markers of angiogenesis in high-risk, early-stage cervical cancer: A Gynecologic Oncology Group study.
    Randall LM; Monk BJ; Darcy KM; Tian C; Burger RA; Liao SY; Peters WA; Stock RJ; Fruehauf JP
    Gynecol Oncol; 2009 Mar; 112(3):583-9. PubMed ID: 19110305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoxia and anaemia in patients with cancer of the uterine cervix.
    Andreu-Martínez FJ; Martínez-Mateu JM
    Clin Transl Oncol; 2005 Sep; 7(8):323-31. PubMed ID: 16185600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of platelet-derived endothelial cell growth factor (PD-ECGF) and its mRNA in uterine cervical cancers.
    Fujimoto J; Sakaguchi H; Hirose R; Ichigo S; Tamaya T
    Br J Cancer; 1999 Mar; 79(7-8):1249-54. PubMed ID: 10098767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumour hypoxia and vascular density as predictors of metastasis in squamous cell carcinoma of the uterine cervix.
    Sundfør K; Lyng H; Rofstad EK
    Br J Cancer; 1998 Sep; 78(6):822-7. PubMed ID: 9743308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantification and prognostic relevance of angiogenic parameters in invasive cervical cancer.
    Tjalma W; Van Marck E; Weyler J; Dirix L; Van Daele A; Goovaerts G; Albertyn G; van Dam P
    Br J Cancer; 1998 Jul; 78(2):170-4. PubMed ID: 9683289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor angiogenesis: an independent prognostic parameter in cervical cancer.
    Bremer GL; Tiebosch AT; van der Putten HW; Schouten HJ; de Haan J; Arends JW
    Am J Obstet Gynecol; 1996 Jan; 174(1 Pt 1):126-31. PubMed ID: 8571995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor angiogenesis in stage IB cervical cancer: correlation of microvessel density with survival.
    Obermair A; Wanner C; Bilgi S; Speiser P; Kaider A; Reinthaller A; Leodolter S; Gitsch G
    Am J Obstet Gynecol; 1998 Feb; 178(2):314-9. PubMed ID: 9500492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of angiogenesis and recurrence-free survival of early stage cervical cancer patients undergoing radical hysterectomy with pelvic lymph node dissection.
    Phoophitphong T; Hanprasertpong J; Dechsukhum C; Geater A
    J Obstet Gynaecol Res; 2007 Dec; 33(6):840-8. PubMed ID: 18001452
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.